Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Reproductive Biology and Endocrinology : RB&E|February 18, 2011
Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilizationAlberto Revelli, Simona Casano, Francesca Salvagno, et al.Best Practice & Research. Clinical Obstetrics & Gynaecology|March 18, 2015
Obesity and female malignanciesChiara Benedetto, Francesca Salvagno, Emilie Marion Canuto, et al.Obstetrics and Gynecology International|February 1, 2012
Oocyte cryostorage to preserve fertility in oncological patientsAlberto Revelli, Emanuela Molinari, Francesca Salvagno, et al.Fertility and Sterility|October 30, 2012
Live birth after orthotopic grafting of autologous cryopreserved ovarian tissue and spontaneous conception in ItalyAlberto Revelli, Gianluigi Marchino, Elisabetta Dolfin, et al.Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|July 24, 2014
Fertility preservation program before ovarotoxic oncostatic treatments: role of the psychological support in managing emotional aspectsAlessandra Razzano, Alberto Revelli, Luisa Delle Piane, et al.Frontiers of Hormone Research|May 6, 2021
Gonadal Failure and Infertility in Cancer Survivors: Clinical Management and Strategies for PreventionMarco Zavattaro, Fabio Lanfranco, Francesca Salvagno, et al.Reproductive Biomedicine Online|December 25, 2013
A slowly reabsorbed, echogenic surgical thread provides a long-lasting ultrasound-detectable marker of grafted ovarian tissueAlberto Revelli, Gian Luigi Marchino, Francesca Salvagno, et al.Journal of Assisted Reproduction and Genetics|March 19, 2020
A prospective randomized trial comparing corifollitropin-α late-start (day 4) versus standard administration (day 2) in expected poor, normal, and high responders undergoing controlled ovarian stimulation for IVFAlberto Revelli, Gianluca Gennarelli, Marta Sestero, et al.Journal of Assisted Reproduction and Genetics|May 23, 2020
Correction to: A prospective randomized trial comparing corifollitropin-α late-start (day 4) versus standard administration (day 2) in expected poor, normal, and high responders undergoing controlled ovarian stimulation for IVFAlberto Revelli, Gianluca Gennarelli, Marta Sestero, et al.Frontiers in Endocrinology|June 1, 2026
Fertility preservation and subsequent reproductive outcomes in female pediatric patients with hematologic malignanciesFrancesca Salvagno, Bernadette Evangelisti, Marta Agù, et al.Pageof 2